RecruitingNCT07221578

Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder

This recruiting study focuses on anxiety and currently lists sites or participation links in United States.

AnxietyOtherFrom 18 Years to 65 Years

In plain English

Key information made simple

This study exists to compare options and see whether the medication VQW-765 offers something meaningfully different. Researchers are trying to understand whether the medication VQW-765 can make support easier to access outside standard clinic visits. For people living with Anxiety, access and fit can matter just as much as the treatment itself. If the findings are useful, they could lead to earlier recognition and more informed decisions later on. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests a mix of remote and in-person participation through a research setting, with sites including Vanda Investigational Site in Phoenix, Vanda Investigational Site in Scottsdale, and Vanda Investigational Site in Encino. Participation appears to involve using a digital tool or support program and giving feedback through check-ins or assessments. The main fit is usually being able to understand the study and consent and matching the main diagnosis, while common reasons not to take part include safety concerns that need urgent care first and active substance or alcohol problems that could affect the results. This is a later-stage study, which usually means a larger group and a closer look at how well the approach holds up.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record

Interested?

Check my eligibility

Study reference: NCT07221578. Your email is the only field you need to provide here.

In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular visits and structured follow-up.

Mixes in-person and remote participation.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com